TLSI:NSD-TriSalus Life Sciences Inc. (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 5.77

Change

-0.06 (-1.03)%

Market Cap

USD 0.19B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

-0.57 (-0.49%)

USD 46.05B
ALGN Align Technology Inc

+0.41 (+0.17%)

USD 18.23B
PODD Insulet Corporation

+2.91 (+1.48%)

USD 13.41B
SWAV Shockwave Medical Inc

N/A

USD 12.57B
BRKR Bruker Corporation

-0.25 (-0.37%)

USD 9.79B
MASI Masimo Corporation

-5.41 (-3.98%)

USD 6.66B
TMDX TransMedics Group Inc

-1.96 (-1.34%)

USD 4.52B
PRCT Procept Biorobotics Corp

-1.86 (-3.00%)

USD 3.54B
AXNX Axonics Modulation Technologie..

-0.19 (-0.28%)

USD 3.44B
IRTC iRhythm Technologies Inc

+7.21 (+7.35%)

USD 3.09B

ETFs Containing TLSI

TADS 4.26 % 0.00 %

N/A

N/A
PSCI Invesco S&P SmallCap Indu.. 2.40 % 0.29 %

-0.82 (0%)

USD 0.18B
SLYV SPDR® S&P 600 Small Cap .. 0.68 % 0.15 %

-0.02 (0%)

USD 3.74B
VIOV Vanguard S&P Small-Cap 60.. 0.66 % 0.20 %

-0.06 (0%)

USD 1.28B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -31.72% 41% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.72% 41% F 21% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.19B 60% D- 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector